Green Paula, an officer at Twist Bioscience Corp, has sold 1,007 shares of the company's common stock. The transaction, reported in a recent SEC filing, was valued at approximately $136,349.51. This sale is part of a series of stock sales by Paula that have occurred over the past few months, indicating ongoing adjustments in compensation and stock vesting.

The sale took place on November 3, 2026, and follows a pattern of stock transactions by Paula Green. The filing reveals that Green has been actively selling shares since August 2026, with previous sales including 1,360 shares on August 21 and 10,088 shares on October 2. These transactions reflect a common practice among executives in the life sciences sector, where stock sales often coincide with compensation adjustments.

Background

Twist Bioscience Corp, based in South San Francisco, California, operates in the biological products industry, specifically focusing on products that do not include diagnostic substances. The company is publicly traded on NASDAQ under the SEC file number 001-38720. Green Paula is a recognized officer within the organization, and her stock sales are closely monitored by investors and analysts alike.

What the Filing Says

The SEC filing, accession number 0001959173-26-007691, indicates that the shares sold were acquired through restricted stock vesting. The filing states, "Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution." This highlights the tax implications often associated with stock sales by executives.

Impact

This transaction may affect various stakeholders, including investors and analysts who track executive compensation and stock performance. The ongoing sales by Green could influence perceptions of the company's financial health and the compensation practices within the life sciences industry.

What's Next

The filing does not say what happens next.